5
report
Learning from COVID-19: Reimagining Public-Private Partnerships in Public Health
The Milken Institute Center for Public Health leveraged our network of thought leaders to maximize
learnings from the COVID-19 pandemic, focused on examining the private sector’s role and responsibility in supp
+ Read More
report
Coalition-Building between the US and China on Women’s Cancer Detection, Treatment, and Care
Cancer is one of the leading causes of death in the US and China. Of the top 10 (by incidence) canc
ers in China, four are women’s cancers, including breast and cervical cancers.
+ Read More
article
An Update from MI Health—July 2024
In This Issue:
article
FasterCures Quarterly Update—July 2024
In This Newsletter
Highlights from Global Conference
Recent Publications
Policy Updates
FasterCures
Program Updates
+ Read More
article
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials
The Milken Institute celebrates the publication of the second iteration of the Food and Drug Adminis
tration (FDA) draft guidance on Diversity Action Plans (DAP) to improve clinical trial diversity by enrolling underrepresented populations in the US.
+ Read More